As a globally operating company headquartered in Germany, CHEPLAPHARM has established a leading and sustainable platform for specialty pharma during the past two decades. We invest worldwide in well-established pharmaceutical brands which have been developed and introduced by research-based pharmaceutical companies. Our deep expertise in this field enables us to sustain the value of these brands for patients and the medical community. In this way we help the research-based pharmaceutical industry divest from older products so they can focus resources on innovation and new product pipelines. This is how we ACHIEVE MORE together.
We take action to ensure the global availability of well-established pharmaceutics – to ACHIEVE MORE for patients and the medical community. This is only possible with an organization of people who are driven to ACHIEVE MORE. If this sounds like you, we would be happy to have you on board.
What matters to our investors also matters to us: acting responsibly and sustainably with maximum transparency. We believe that business success, ethical conduct and patient wellbeing all fit together magnificently. Please and explore the investment opportunities we offer. And let’s ACHIEVE MORE together.
EURm turnover in FY 2022